Overview
PATENCY-2
Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease
Objective
This research study is enrolling patients with chronic kidney disease from Lake Washington Vascular who will undergo a Radiocephalic Arteriovenous Fistula creation to create a new access to their bloodstream for hemodialysis. This study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase.
Study Coordinator(s)
Krissa Gunderson, CRC: 425.732.5958, krissag@lkwv.com
Irina Stipek, CRC: 425.732.5959, irinas@lkwv.com
Complete the online contact information form.
Learn More
Clinical Trial Categories
Vascular/Surgical
View all hospital services
Make a gift
